1. Home
  2. VLYPN vs MRK Comparison

VLYPN vs MRK Comparison

Compare VLYPN & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLYPN
  • MRK
  • Stock Information
  • Founded
  • VLYPN N/A
  • MRK 2000
  • Country
  • VLYPN
  • MRK United States
  • Employees
  • VLYPN 3749
  • MRK N/A
  • Industry
  • VLYPN
  • MRK Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLYPN
  • MRK Health Care
  • Exchange
  • VLYPN NYSE
  • MRK Nasdaq
  • Market Cap
  • VLYPN N/A
  • MRK 260.8B
  • IPO Year
  • VLYPN N/A
  • MRK N/A
  • Fundamental
  • Price
  • VLYPN $25.20
  • MRK $99.66
  • Analyst Decision
  • VLYPN
  • MRK Buy
  • Analyst Count
  • VLYPN 0
  • MRK 15
  • Target Price
  • VLYPN N/A
  • MRK $125.36
  • AVG Volume (30 Days)
  • VLYPN N/A
  • MRK 9.5M
  • Earning Date
  • VLYPN N/A
  • MRK 02-04-2025
  • Dividend Yield
  • VLYPN N/A
  • MRK 3.25%
  • EPS Growth
  • VLYPN N/A
  • MRK 165.47
  • EPS
  • VLYPN N/A
  • MRK 4.78
  • Revenue
  • VLYPN N/A
  • MRK $63,174,000,000.00
  • Revenue This Year
  • VLYPN N/A
  • MRK $7.50
  • Revenue Next Year
  • VLYPN N/A
  • MRK $5.14
  • P/E Ratio
  • VLYPN N/A
  • MRK $20.85
  • Revenue Growth
  • VLYPN N/A
  • MRK 6.51
  • 52 Week Low
  • VLYPN N/A
  • MRK $94.48
  • 52 Week High
  • VLYPN N/A
  • MRK $134.63
  • Technical
  • Relative Strength Index (RSI)
  • VLYPN N/A
  • MRK 47.97
  • Support Level
  • VLYPN N/A
  • MRK $98.05
  • Resistance Level
  • VLYPN N/A
  • MRK $102.97
  • Average True Range (ATR)
  • VLYPN 0.00
  • MRK 1.65
  • MACD
  • VLYPN 0.00
  • MRK 0.18
  • Stochastic Oscillator
  • VLYPN 0.00
  • MRK 32.67

About VLYPN VALLEY NATIONAL BANCORP FIXED RATE RESET PERP PFD SER C

Valley National Bancorp is a bank holding company whose principal wholly-owned subsidiary is Valley National Bank. It provides a full range of commercial, retail, and trust and investment services largely through its offices and ATM network throughout northern and central New Jersey, New York City Long Island, Florida, and Alabama. The segments of the group are commercial lending, consumer lending, investment management, and corporate and other adjustments, of which key interest income is derived from the commercial lending segment. In recent years, the company has focused on acquiring companies that operate outside of traditional banking and has emphasized wealth and capital management.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Share on Social Networks: